Health
UK closer to human problem trials of potential COVID-19 vaccines that infect volunteers – Republic World – Republic World
Preliminary work for trials, which aims to determine the efficacy of a vaccine candidate is being carried out by UK’s Open Orphan plc (ORPH) hVIVO.
On October 15, the UK’s biotech agency announced that its “Human problem” trials of potential COVID-19 vaccines could become a reality where volunteers are deliberately infected with SARS-CoV-2 as the pharmaceutical firm signed a contract with the UK’s government to procure the strains of the virus. Preliminary work for the trials, which aims to determine the efficacy of a vaccine candidate is being carried out by a unit of pharmaceutical service company Open Orphan plc (ORPH) hVIVO.
The model …
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News11 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred